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Summary Indirect evidence suggests that abnormal regulation of B cells exists in Hodgkin's disease (HD)
due, perhaps, to the sequestration of regulatory T-lymphocyte subpopulations in the spleen in this condition.
Other work implicates the B-cell itself in this abnormality. In this study we have attempted to measure
regulatory T-cell function by quantitating spontaneous and Concanavalin A(Con A)-induced suppressor
activity in T-enriched spleen cells from control and HD spleens for pokeweed mitogen(PWM)-induced
immunoglobulin (Ig) production. Using this polyclonal system, HD patients' spleen T-lymphocytes could not
be shown to differ markedly from the control series. Cells capable of spontaneous and mitogen-induced
modulation of Ig synthesis were present in both populations and showed a reciprocal relationship implying
the activation ofthe same cell type. In this respect HD and control spleen resembled peripheral blood.
A limited parallel investigation of PWM-regulatory activity in cells from spleen and peripheral blood from
individual patients was also undertaken. Individual patients showed wide variation in suppression between the
two compartments and, therefore, measurements of functional capacity in blood alone may not provide a true
estimate oftotal regulatory capacity in lymphoma patients.
The lectin Concanavalin A (Con A) has been
extensively used as a tool for the study of immuno-
regulation in man (Shou et al., 1976; Smith &
Svejgaard, 1981; Dwyer & Johnson, 1981). The
inhibitory activity induced by this mitogen is
considered to be a normal functional characteristic
of T-cells, loss of which may be associated with
various autoimmune phenomena (Fauci et al., 1978;
Sakane et al., 1978). Con A activates a hetero-
geneous pool of cells (Damle & Gupta, 1982)
within which distinct subpopulations of induced
suppressor cells regulate immunoglobulin (Ig)
synthesis and proliferation in mixed lymphocyte
culture (Lobo & Spencer, 1979; Herscowitz et al.,
1980). When pokeweed mitogen (PWM) induced Ig
synthesis is used to assay for Con A-induced
suppression, control as well as Con A-induced cells
may exert inhibitory activity (Schwartz et al., 1977;
Haynes & Fauci, 1978; Lipsky et al., 1978). This
"spontaneous" suppressor activity of control cells is
thought to reflect the expansion of a pre-existent
inhibitory cell sub-population in vitro (Lipsky et al.,
1978).
In HD there is an increase in suppressor activity
for proliferation induced by mitogens (Goodwin et
al., 1977; Twomey et al., 1980; Schulof et al., 1981)
or cell bound alloantigens (Twomey et al., 1975;
Hillinger & Hertzig, 1978; Engleman et al., 1979)
which may contribute to the defect in cell-mediated
immunity present in these patients (Twomey et al.,
1975; Schulof et al., 1981). All these studies,
however, have employed peripheral blood mono-
nuclear cells (PB-MNC) and little information is
available on the regulatory activity of tissue
lymphocytes in this disease. It is clear that immuno-
logical changes occur in the spleen of HD patients
prior to involvement with tumour (Payne et al.,
1976). In particular, manifestations of B-cell hyper-
activity in the spleen (Longmire et al., 1973; Payne
et al., 1976; Jones et al., 1978) and bone marrow
(Longmire et al., 1974; Kass & Votaw, 1975)
together with increased levels of polyclonal Ig in
the serum of these patients (Landaas et al., 1979)
imply a defect of B-cell regulation in HD.
In this study the Con A-induced suppressor
activity of splenic lymphocytes and PB-MNC from
HD patients and control subjects for PWM-induced
Ig synthesis was determined in an attempt to
further investigate B-cell regulation in HD.
Materials and methods
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Subjects
Fresh spleen tissue was obtained at staging
laparotomy from 14 patients with HD, of which 3
showed histological evidence of disease
involvement. In this group, 3 patients had lympho-
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cyte predominant disease, 10 showed the nodular
sclerosing pattern of HD and one patient had the
mixed cellularity form. Clinically, stage Ta
predominated in the uninvolved group. Patients
with histological evidence of involvement in the
spleen were staged as Ila or Ilb.
Eight non-lymphomatous spleens showing normal
histology were also obtained from patients
incidental to abdominal surgery or from road
accident cases, Heparinized venous peripheral blood
was obtained from 5 of the HD spleen donors at
the time of staging laparotomy. Normal heparinized
venous peripheral blood was obtained from healthy
laboratory personnel.
Isolation ofmononuclear cells
Peripheral blood mononuclear cells (PB-MNC)
were isolated by Ficoll/Triosil gradient sedi-
mentation (Payne et al., 1976). All tissue culture
reagents were obtained from Gibco, Europe Ltd;
(Paisley, Scotland). Cells were washed three times in
calcium and magnesium free Hank's Balanced Salt
Solution (HBSS-CMF) and resuspended in RPMI-
1640 supplemented with penicillin (100 unitml1),
streptomycin (100mgml-1), glutamine (20mm) and
10% inactivated foetal bovine serum (FBS).
PB-MNC preparations usually contained 0-4%
red blood cells, 0-2% granulocytes and 5-35%
monocytes. Viability of the final mononuclear
suspension trypan blue exclusion was >99%.
Fresh spleen tissue was minced in HBSS-CMF
and filtered through a wire sieve. Splenic mono-
nuclear cells were then isolated from this
suspension as described for peripheral blood.
Spleen mononuclear cell suspensions contained
89+3% lymphocytes, 6+4% non-specific esterase
positive macrophages and 5+4% polymorpho-
nuclear leucocytes.
Preparation of T-cell enriched and T-cell depleted
MNC
Splenic or peripheral blood MNC at
2 x 106cellsml-l in HEPES buffered RPMI-1640
(HRPMI) were mixed with equal volumes of a 1%
suspension of neuraminidase treated sheep red
blood cells (SRBC) in HRPMI with 2% FBS. This
suspension was incubated at 37°C for 10min,
centrifuged and re-incubated on ice for at least 2h.
T-enriched cells were prepared by further sedi-
menting the rosetting cells through a Ficoll/Triosil
gradient, lysing the SRBC with TRIS buffered
0.83% ammonium chloride and washing with
HBSS-CMF. T-depleted cells were recovered from
the interface and washed in HBSS-CMF.
Proliferative responses to mitogens
Tissue or peripheral blood mononuclear cells
(2 x 105) in 0.2ml of RPMI 1640 supplemented with
10% FBS were cultured in round-bottomed micro-
titre plates (Sterilin Ltd., Teddington, UK) at 37°C
in an atmosphere of 5% CO2 in air. PWM or Con
A (1O0g) at a range of concentrations were added
to triplicate cultures to obtain dose-response curves
to these mitogens. After 3 days in culture, 0.2pCi
of thymidine in 10p1 of medium (25 Cimmol-1,
Radiochemical Centre, Amersham, UK) was added
to each well. Between 18 and 24h later the cells
were harvested onto glass fibre filter paper
(Whatman, Maidenhead, UK) using an automated
harvester (Minivent, London, UK). Discs of air
dried filter carrying deposited cells were placed in
plastic scintillation insert vials (Sterilin, Teddington,
UK) to which 0.5ml of scintillation fluid was
added. The radioactivity of the samples was
measured in a Packard Tricarb liquid scintillation
counter (model 544). Results were expressed as the
mean counts per minute (cpm) of triplicate cultures.
Peripheral blood, normal spleen MNC showed
peak responses to Con A when the final concen-
tration of this mitogen in the culture was in the
range of 5-20pgml-1 and peak responses to PWM
when -1/100 final dilution of this mitogen was
used. In subsequent experiments, 10pgml-' and
20pg of Con A was used to induce peripheral
blood and splenic suppressor cells, while a 1/100
final dilution of PWM was used to stimulate Ig
synthesis in the assay cultures. When T-enriched
and T-depleted fractions of normal peripheral
blood, normal spleen or HD spleen mononuclear
cells were stimulated with 10/pgml-' of Con A,
suppressor activity for PWM-induced Ig synthesis
was present in the T-enriched fractions with
minimal suppression in the T-depleted cells. T-
enriched fractions were therefore used to determine
the Con A-induced suppressor activity of normal
and HD spleens in order to standardize the
populations under study.
Induction ofsuppressor cells by Con A
Cells (5 x 106) from the prepared cell populations in
5ml of RPMI 1640 supplemented with 10% FBS
were incubated with 10pgml-' of Con A (Miles
Laboratories Ltd., Slough, UK - batch number
180, cat. 79-003) for 18-24h in an atmosphere of
5% CO2 in air. Control cells were incubated
without Con A. At the end of the culture period,
control and Con A activated cells were washed
twice in 3M-methyl-D-mannopyranoside (Sigma
Chemical Company, Poole, Dorset, UK) and once
in complete medium to remove cell-bound Con A
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10% FBS. The viability of control and Con A
activated cells was always >90% after washing.
Responder cells
PB-MNC from normal individuals were prepared in
parallel with the washed cells from the primary
culture. One or more of 6 normal volunteers were
used as responders for the determination of
suppressor activity in both control and HD
patients, chosen as they showed high Ig production
in response to PWM. The responder cells were
adjusted to a final concentration of 106cells ml-1
in complete RPMI 1640 with 10% FBS.
Assayfor suppressor cell activity
Aliquots (0.15ml) of the responder cell suspension
(106cellsml-1) were added in triplicate to the wells
of round bottomed microtitre plates (Sterilin Ltd.,
Teddington, UK). To these cells were added 0.05ml
of RPMI alone, control cells (106cellsml-1) or Con
A-induced cells (106cellsml-1) giving a final
volume of 0.2ml in each well and a 3: 1 responder
to control or suppressor cell ratio in the co-
cultures. Aliquots (0.2ml; 106ml-1) of control or
Con A activated cells were also cultured alone to
assess their contribution to the final Ig synthetic
response. Each well received 11 p1 of PWM (Gibco
Biocult UK Ltd., batch A405109, cat. 670-5360)
resulting in a 1/100 final dilution of the stock
solution of this mitogen. The culture plates were
incubated at 37°C in an atmosphere of 5% CO2 in
air for 7 days. On completion of this culture period,
viable cell yields were measured and cytospin
preparations made from triplicate wells. Good
agreement was found when two different
responders were used in the suppressor assay. The
mean suppression was, therefore, determined when
more than one responder was used in a single
experiment.
Immunofluorescent stainingfor intracellular Ig
Cytospin preparations were fixed by immersion, in
dry acetone at -20°C, stained with a polyvalent
FITC-conjugated sheep anti-human Fab antibody
(Tenovus Laboratory, Southampton, UK) and
examined under UV illumination on a Leitz
Orthoplan microscope. The percentage of cyto-
plasmic Ig positive cells (CIg+) was established by
counting at least 300 cells/slide. The number of
cytoplasmic Ig positive cells per well (CIg+/well) is
calculated as follows:
CIg+/well =%CIg+ x
number of viable cells/well
100
Calculation ofsuppression
Percentage suppression induced by Con A is
calculated as follows:
rmean CIg+/well in Con A co-cultures)
1-S x10
1 mean CIg+/well in control cultures J
Percentage spontaneous suppression is calculated as
follows:
Jmean CIg+/well with responder cells alone
mean CIg+/well in control co-cultures J
x 100
Statistical analyses were performed using the Mann-
Whitney U test.
Results
Patterns ofspontaneous and Con A-induced
suppression ofperipheral blood and spleen
The addition of Con A activated T-enriched or
unfractionated normal peripheral blood MNC to
PWM stimulated responder cells suppressed Ig
synthesis in comparison with control cells.
Furthermore, the co-culture of control T-enriched
unfractionated peripheral blood MNC with PWM
stimulated responder cells also spontaneously
suppressed Ig production in most cases as
compared with the same number of responder cells
cultured alone with PWM. The Con A induced
suppressor activity is, therefore, measurable above
the spontaneous suppressor activity.
When the spontaneous and Con A-induced
suppression by T-enriched splenic MNC was
studied (Tables I and II), it was found that control
and Hodgkin's lymphoma patients showed two
patterns of inhibition, indicated by Group 1 and
Group 2 in the tables. Into Group 1 we have placed
patients with higher apparent Con A-induced than
spontaneous suppressor activity. Group 2 showed
markedly higher spontaneous suppression in
comparison with Con A-induced activity. There
was no correlation between either Group 1 or
Group 2 suppression and the age or sex of the
patients. Furthermore, in the lymphoma patients,
there was no relationship between histological type
of disease, involvement of spleen with tumour,
clinical stages of disease, presence of constitutional
symptoms and either pattern of suppression.352 A.N. AKBAR et al.
Table I Group 1 spleens. Spleens showing lower
spontaneous than Con A-induced suppression. HD spleen
showing significantly higher spontaneous suppressor
activity than normal (P=0.018) as assessed by the Mann-
Whitney U test.
% Suppression
Name Diagnosis Spontaneous Con A-induced
DJ Normal 6.9 43.2
LF Normal -47.9 59.0
JB Normal -15.1 45.2
MJ Normal 1.9 39.0
MS Normal 60.7 74.1
Mean 1.3 52.1
RS HD 1.4 50.6
CC HD -8.2 28.9
UC HD -23.5 37.0
GG HD 42.1 61.2
MW HD 9.4 22.6
EM HD 26.2 72.2
DB HD 25.4 30
Mean 10.4 43.2
Table II Group 2 spleens. Spleens showing higher
spontaneous than Con A-induced suppression. HD spleen
showing significantly lower spontaneous suppressor
activity than normal (P=0.018) as assessed by the Mann-
Whitney U test.
% Suppression
Name Diagnosis Spontaneous Con A-induced
RF Normal 75.4 21.7
AW Normal 70.8 5.2
PC Normal 49.4 7.2
Mean 65.2 11.4
DT HD 14.9 -6.25
KG HD 44.4 -7.7
DM HD 24.3 20.4
DA HD 37.1 -21.9
DW HD 47.7 13.2
Mean 33.7 -2.3
Comparison ofsuppression in HD and control spleens
In total the spontaneous and Con A-induced
suppression mediated by the T-enriched cells of 8
normal spleens and a maximum of 14 HD spleens
were studied (Figure 1). -The mean spontaneous
suppression for normal and HD spleen was 29.8%,
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Figure 1 Inhibition of the PWM induction of Ig
containing cells by peripheral blood or splenic lympho-
cytes cultured alone (spontaneous) or with 10 or 20 ug
Con A. Each point represents the mean of 3
determinations, negative values represent stimulation.
(0) normal spleen; (A) Hodgkin's disease spleen.
and 20.1% respectively. When splenic T-enriched
cells were incubated with 10l gml-P Con A before
co-culture with PWM stimulated responder cells a
mean of 28.9% and 31.4% suppression of Ig
synthesis resulted for normal and HD spleens
respectively. There was no significant difference in
spontaneous or Con A-induced suppression
between the 2 spleen populations as assessed by the
Mann-Whitney U test. Within the HD group, no
correlation was observed between clinical stage of
disease, A or B symptoms, histological type of
disease or involvement of spleen with tumour and
spontaneous or Con A-induced suppression.
Suppressor activity simultaneously measured in the
peripheral blood andspleen oflymphoma patients
Venous peripheral blood was obtained for 6 HD
patients who were undergoing staging laparotomy.
Simultaneous suppressor experiments were under-
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taken with cells from both blood and spleen.
Insufficient volumes of HD peripheral blood were
available to allow the T-enrichment of this
population. The spleen T-enriched fractions
contained a mean of 83.5% (range 78%-93.3%)
while the unfractionated PB-MNC fractions
contained 60.3% (range 48.6%-69.5%) of cells that
rosetted with SRBC. Less than 1% of splenic T-
enriched cells stained with non-specific esterase
while a mean of 14.1% (range 7.5%-23.4%) of the
unfractionated HD PB-MNC contained this
enzymic activity. There were no significant
differences in suppression between lymphoma peri-
pheral blood and spleen (Figure 2). Individual
patients, however, showed a large discrepancy in
suppression between the two lymphoid
compartments. The suppressor activity induced by
10 and 20 ig of Con A in the unfractionated PB-
MNC of 5HD patients was significantly lower than
that induced in identically prepared PB-MNC of
the whole control group consisting of blood from
12 normal individuals (P=0.05). Normal and HD
patients PB-MNC were regularly assayed in parallel
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on responders selected from the same donor panel.
These data are presented in Figure 3. There was no
significant difference in spontaneous suppressor
activity measured in the blood, between control and
HD patients. A mean of 61.5% (range 45.0%-
72.5%) of the cells in the control group formed
rosettes with sheep red blood cells before activation
by Con A while the figures for HD patients was
60.3% (range 48.6%-69.5%). The mean percentage
of cells that stained positively for non-specific
esterase was 17.6% (range 10.1%-34.0%) in the
control group and 14.1% (range 7.5%-23.4%) in
the HD patients. The differences in suppression
between controls and HD patients is, therefore,
unlikely to be due to differences in the composition
of the cell population under study.
It was not possible to obtain sufficient HD
patient blood samples to enable correlation between
suppression and clinical stage or histological type
of disease.
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Figure 2 Spontaneous and Con A induced
suppression of the PWM induction of Ig containing
cells by lymphocytes from the blood and spleen of
individual patients. Blood and spleen preparations
from individual patients have the same symbol. Mean
of 3 determinations, negative values represent
stimulation.
Spontaneous
suppression
I
* V
0
0
0 S
Con A induced
10 mg mi-1
I
*
0
0
V
V
V
V
Suppression
20 pg ml-1
1
0
v
V
-
v
V
Figure 3 Spontaneous and Con A induced
suppression of the PWM induction of Ig containing
cells by lymphocytes from the blood of HD patients
(V) and normal controls (0). Mean of 3 deter-
minations, negative values represent stimulation.
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Viable cell recovery after culture with PWMfor
7 days
Viable cell recoveries were measured after 7 days in
the PWM assay. Table III shows the mean viable
cell recoveries of the experimental groups studied.
The number of cells present at the initiation of
culture was 1.5 x 105 for the responder alone and
2.0 x 105 in co-cultures of responder and control or
Con A-activated T-enriched cells. After 7 days, co-
cultures containing Con A-activated cells
consistently showed greater viable cell yields than
co-cultures containing responder and control cells
or cultures containing responder cells alone. Both
control and Con A-activated T-enriched cells
contained >1% of GIg+ cells after culture alone
with PWM for 7 days.
Discussion
The majority of studies concerning Con A-induced
suppressor activity in man have investigated peri-
pheral blood mononuclear cells (Dwyer & Johnson,
1981). A few authors have described the ability of
Con A activated splenic lymphocytes to suppress
both Ig synthesis (Kraukauer et al., 1980; Ilfeld &
Kraukauer, 1982) and alloantigen induced prolifera-
tive responses (Sampson et al., 1975). These studies
did not compare blood and spleen. In this study
splenic and peripheral blood MNC showed similar
proliferative dose response curves to both PWM
and Con A. Further, Con A induced suppressor
activity was restricted to the T-enriched fractions of
spleen cells, implying a common identity for the
mitogen activated suppressor cell in both
compartments. The levels of inhibition of Ig
synthesis observed with both peripheral blood and
splenic suppressor cells were similar.
Several authors have described a range of effects
on PWM activation mediated by peripheral blood
lymphocytes in culture, ranging from stimulation to
marked suppression (Schwartz et al., 1977; Haynes
& Fauci, 1978; Lipsky et al., 1978). Our results
with T-enriched spleen cell fractions show that this
is also the case in spleen. Spontaneous suppressor
activity, attributed in the blood to the spontaneous
activation of suppressor cells under culture
conditions (Schwartz et al., 1977) was apparent in
mitogen-free cultures of cells from HD and control
spleens. It is also clear from these results that there
is a reciprocal relationship between spontaneous
suppression and that induced by Con A, suggesting
that in' both cases the activated cell represents
identical or overlapping populations.
Increased spontaneous suppression of
proliferative responses has been found in HD
(Twomey et al., 1975; Goodwin et al., 1977;
Twomey et al., 1980; Hillinger & Hertzig, 1978;
Engleman, 1979) and may contribute to the defect
in cell mediated immunity which is characteristic of
patients with this disease. Con A-induced
suppression of lymphocyte proliferation is either
normal (Van Haelen & Fisher, 1981) or decreased
(Schulof et al., 1980). In this study we have
determined the percentage of Ig synthesizing cells at
the end of the culture period and the results may,
Table III Viable cell recovery
Mean + s.d. viable cell recovery x 10 5
Respondera
RespondeP + Con A
Respondera + controls activated
Population under study No. experiments alone cells cells
Unfractionated
normal PB-MNC 12 1.51+0.45 1.83+0.49 2.66+0.43
T-enriched
normal PB-MNC 7 1.98 +0.35 2.2 +0.4 2.6 +0.5
T-enriched
normal spleen MNC 8 1.4 +0.4 1.53 +0.05 2.09+0.7
T-enriched
Non-HD lymphoma spleen
MNC 3 1.26 1.73 1.97
T-enriched
HD spleen MNC 14 1.8 +0.46 1.95+0.8 2.32+0.67
aViable cell recovery after 7 days in culture with a 1/100 final dilution of PWM.SUPPRESSION IN HODGKIN'S DISEASE 355
therefore, reflect the activity of a different
population from those concerned with the
inhibition of proliferation (Lobo & Spencer, 1979;
Herscowitz et al., 1980). It is clear from Tables I
and II that in this system HD spleen preparations
resemble the normal spleen pattern. When splenic
suppressor populations were divided into those
exhibiting low spontaneous suppression and those
with natural activity (Groups 1 and 2 respectively),
control and HD patients could be placed into both
groups. Thus, although evidence of a defect in B-
cell regulation exists in HD (Longmire et al., 1973,
1974; Kass & Votaw, 1975; Payne et al., 1976;
Jones et al., 1977) it was not possible to show a
clear difference between control and HD patients
using the Con A-induced system. In this respect it
is interesting to note that Souhami et al. (1981),
working with a specific antigen found evidence for
a B-cell defect separate from the T-cell
abnormalities present in this lymphoma. It is
possible that the overall level of spontaneous
suppression is lower in HD (P=0.018 in the Group
2) but the relatively small number of spleens in each
group render this result difficult to substantiate.
In five cases it proved possible to determine the
suppressor activity of both HD patients spleen and
blood lymphocytes in parallel. As a group there
was no difference between blood and spleen
lymphocytes, though individual patients showed
wide variation in the suppression observed in both
compartments. Clearly, therefore, peripheral blood
values for functional activity are not always
representative of the tissue values in lymphoma.
Further, whilst overall Con A suppression of PWM
stimulated Ig synthesis was lower in HD blood than
controls, as described by Schulof et al. (1980) for
Con A suppression of proliferation, with the small
sample available in this study we were unable to
demonstrate a consistent sequestration of a
particular subset of lymphocytes in the spleen in
HD, (de Sousa et al., 1977, 1978; Gupta & Tan,
1980).
The assay system employed the alteration of
numbers of cytoplasmic Ig positive cells following
PWM stimulation of PB MNC from a limited
normal donor panel co-cultured with MNC from
HD samples. Viable cell recovery (Table III) was
never less in mitogen containing cultures than in
controls. It is, therefore unlikely that apparent
suppression was a result of cytotoxicity. Further,
the comparison of figures for viable cell recovery
for different control and experimental groups with
those for the suppression obtained shows that
dilution due to cell proliferating does not account
for the observed reduction in Ig containing cells.
In conclusion, the data presented shows patterns
of suppression of PWM-induced immunoglobulin
synthesis in the spleen which resemble those
described for peripheral blood. With the use of Con
A to induce suppression and in contrast to other
functions we have measured (Payne et al., 1976; Al
Sam et al., 1982) we have not obtained convincing
evidence of either the loss or sequestration of
suppressor cells in HD spleens. It is also clear from
the parallel studies undertaken that measurements
of immune function in the blood in malignant
lymphoma may be widely discordant from those
obtained in relevant lymphoid organs, the data,
therefore, indicates the importance of measuring
more than one compartment in this type of study.
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